PrPC protected Oct4, a marker of colon cancer stem cells, from degradation by inducing heat shock protein 1 like (HSPA1L) when in response to co‐treatment with 5‐FU and melatonin (48). The gene discussed is PRNP; the disease is malignant colon neoplasm.